
Delaware | 01-0616867 | |||
(State or Other Jurisdiction of Incorporation) | (I.R.S. Employer Identification No.) |
Title of each class | Trading Symbol | Name of each exchange on which registered | ||
Common Stock, $0.001 par value | ERII | The Nasdaq Stock Market LLC |
Page No. | ||
Condensed Consolidated Balance Sheets — March 31, 2025 and December 31, 2024 | ||
Condensed Consolidated Statements of Operations — Three Months Ended March 31, 2025 and 2024 | ||
Condensed Consolidated Statements of Comprehensive Loss — Three Months Ended March 31, 2025 and 2024 | ||
Condensed Consolidated Statements of Stockholders’ Equity — Three Months Ended March 31, 2025 and 2024 | ||
Condensed Consolidated Statements of Cash Flows — Three Months Ended March 31, 2025 and 2024 | ||
Exhibit Index | ||
•our belief that our PX offers market-leading value with the highest technological and economic benefit; |
•our belief that leveraging our pressure exchanger technology will unlock new commercial opportunities in the future; |
•our belief that our PX G1300™ can contribute to help make CO2-based refrigeration more economically viable in a broader range of climates; |
•our belief that our technology helps our customer achieve environmentally sustainable operations; |
•our expectation that sales outside of the U.S. will remain a significant portion of our revenue; |
•the scale of the environmental impact from the use of our solutions; |
•the timing of our receipt of payment for products or services from our customers; |
•our belief that our existing cash and cash equivalents, our short and/or long-term investments, and the ongoing cash generated from our operations, will be sufficient to meet our anticipated liquidity needs for the foreseeable future, with the exception of a decision to enter into an acquisition and/or fund investments in our latest technology arising from rapid market adoption that could require us to seek additional equity or debt financing; |
•our expectations relating to the amount and timing of recognized revenue from our projects; |
•our expectation that we will continue to receive a tax benefit related to U.S. federal foreign-derived intangible income and research and development tax credit; |
•the outcome of proceedings, lawsuits, disputes and claims; |
•the impact of losses due to indemnification obligations; |
•other factors disclosed under the MD&A and Part I, Item 3, “Quantitative and Qualitative Disclosures about Market Risk,” and elsewhere in this Form 10-Q. |
March 31, 2025 | December 31, 2024 | ||
(In thousands) | |||
ASSETS | |||
Current assets: | |||
Cash and cash equivalents | $49,137 | $29,627 | |
Short-term investments | 34,408 | 48,392 | |
Accounts receivable, net | 32,389 | 64,066 | |
Inventories, net | 32,410 | 24,906 | |
Prepaid expenses and other assets | 6,248 | 6,665 | |
Total current assets | 154,592 | 173,656 | |
Long-term investments | 23,185 | 21,832 | |
Deferred tax assets, net | 10,645 | 9,004 | |
Property and equipment, net | 14,585 | 15,424 | |
Operating lease, right of use asset | 9,168 | 9,695 | |
Goodwill | 12,790 | 12,790 | |
Other assets, non-current | 429 | 391 | |
Total assets | $225,394 | $242,792 | |
LIABILITIES AND STOCKHOLDERS’ EQUITY | |||
Current liabilities: | |||
Accounts payable | $3,404 | $3,109 | |
Accrued expenses and other liabilities | 11,272 | 17,728 | |
Lease liabilities | 2,357 | 2,020 | |
Contract liabilities | 1,401 | 571 | |
Total current liabilities | 18,434 | 23,428 | |
Lease liabilities, non-current | 8,751 | 9,297 | |
Other liabilities, non-current | 96 | 57 | |
Total liabilities | 27,281 | 32,782 | |
Commitments and contingencies (Note 7) | |||
Stockholders’ equity: | |||
Common stock | 67 | 66 | |
Additional paid-in capital | 237,550 | 235,010 | |
Accumulated other comprehensive income | 75 | 98 | |
Treasury stock | (135,405) | (130,870) | |
Retained earnings | 95,826 | 105,706 | |
Total stockholders’ equity | 198,113 | 210,010 | |
Total liabilities and stockholders’ equity | $225,394 | $242,792 | |
Three Months Ended March 31, | |||
2025 | 2024 | ||
(In thousands, except per share data) | |||
Revenue | $8,065 | $12,090 | |
Cost of revenue | 3,607 | 4,955 | |
Gross profit | 4,458 | 7,135 | |
Operating expenses: | |||
General and administrative | 8,574 | 7,566 | |
Sales and marketing | 4,906 | 6,152 | |
Research and development | 3,001 | 4,351 | |
Restructuring charges | 539 | — | |
Total operating expenses | 17,020 | 18,069 | |
Loss from operations | (12,562) | (10,934) | |
Other income (expense): | |||
Interest income | 1,073 | 1,442 | |
Other non-operating income (expense), net | 6 | (53) | |
Total other income, net | 1,079 | 1,389 | |
Loss before income taxes | (11,483) | (9,545) | |
Benefit from income taxes | (1,603) | (1,285) | |
Net loss | $(9,880) | $(8,260) | |
Net loss per share: | |||
Basic | $ (0.18) | $ (0.14) | |
Diluted | $ (0.18) | $ (0.14) | |
Number of shares used in per share calculations: | |||
Basic and diluted | 54,902 | 57,102 | |
Three Months Ended March 31, | ||||
2025 | 2024 | |||
(In thousands) | ||||
Net loss | $(9,880) | $(8,260) | ||
Other comprehensive loss, net of tax | ||||
Foreign currency translation adjustments | (16) | 28 | ||
Unrealized loss on investments | (7) | (44) | ||
Total other comprehensive loss, net of tax | (23) | (16) | ||
Comprehensive loss | $(9,903) | $(8,276) | ||
Three Months Ended March 31, | ||||
2025 | 2024 | |||
(In thousands, except shares) | ||||
Common stock | ||||
Beginning balance | $66 | $65 | ||
Issuance of common stock, net | 1 | — | ||
Ending balance | 67 | 65 | ||
Additional paid-in capital | ||||
Beginning balance | 235,010 | 217,617 | ||
Issuance of common stock, net | 615 | 1,190 | ||
Stock-based compensation | 1,925 | 3,315 | ||
Ending balance | 237,550 | 222,122 | ||
Accumulated other comprehensive income (loss) | ||||
Beginning balance | 98 | (44) | ||
Other comprehensive loss | ||||
Foreign currency translation adjustments | (16) | 28 | ||
Unrealized loss on investments | (7) | (44) | ||
Total other comprehensive loss, net | (23) | (16) | ||
Ending balance | 75 | (60) | ||
Treasury stock | ||||
Beginning balance | (130,870) | (80,486) | ||
Common stock repurchased | (4,535) | — | ||
Ending balance | (135,405) | (80,486) | ||
Retained earnings | ||||
Beginning balance | 105,706 | 82,656 | ||
Net loss | (9,880) | (8,260) | ||
Ending balance | 95,826 | 74,396 | ||
Total stockholders’ equity | $198,113 | $216,037 | ||
Common stock issued (shares) | ||||
Beginning balance | 66,182,906 | 65,029,459 | ||
Issuance of common stock, net | 350,146 | 448,455 | ||
Ending balance | 66,533,052 | 65,477,914 | ||
Treasury stock (shares) | ||||
Beginning balance | 11,397,045 | 8,148,512 | ||
Common stock repurchased | 279,295 | — | ||
Ending balance | 11,676,340 | 8,148,512 | ||
Total common stock outstanding (shares) | 54,856,712 | 57,329,402 | ||
Three Months Ended March 31, | ||||
2025 | 2024 | |||
(In thousands) | ||||
Cash flows from operating activities: | ||||
Net loss | $(9,880) | $(8,260) | ||
Adjustments to reconcile net loss to cash provided by operating activities | ||||
Stock-based compensation | 1,963 | 3,283 | ||
Depreciation and amortization | 962 | 1,029 | ||
Right of use asset amortization | 464 | 431 | ||
Accretion (amortization) of discounts (premiums) on investments | (231) | (231) | ||
Deferred income taxes | (1,641) | (1,328) | ||
Impairment of long-lived assets | 353 | — | ||
Other non-cash adjustments | 21 | 116 | ||
Changes in operating assets and liabilities: | ||||
Accounts receivable, net | 31,677 | 21,882 | ||
Contract assets | 378 | — | ||
Inventories, net | (7,645) | (5,723) | ||
Prepaid and other assets | (37) | (545) | ||
Accounts payable | 176 | 1,140 | ||
Accrued expenses and other liabilities | (6,712) | (7,589) | ||
Contract liabilities | 830 | 2,292 | ||
Net cash provided by operating activities | 10,678 | 6,497 | ||
Cash flows from investing activities: | ||||
Maturities of marketable securities | 27,224 | 16,534 | ||
Purchases of marketable securities | (14,369) | (20,783) | ||
Capital expenditures | (191) | (824) | ||
Proceeds from sales of fixed assets | 10 | 87 | ||
Net cash provided by (used in) investing activities | 12,674 | (4,986) | ||
Cash flows from financing activities: | ||||
Net proceeds from issuance of common stock | 616 | 1,190 | ||
Repurchase of common stock | (4,490) | — | ||
Net cash (used in) provided by financing activities | (3,874) | 1,190 | ||
Effect of exchange rate differences on cash and cash equivalents | 33 | (19) | ||
Net change in cash, cash equivalents and restricted cash | 19,511 | 2,682 | ||
Cash, cash equivalents and restricted cash, beginning of year | 29,757 | 68,225 | ||
Cash, cash equivalents and restricted cash, end of period | $49,268 | $70,907 | ||
Three Months Ended March 31, 2025 | Three Months Ended March 31, 2024 | |||||||||||
Water | Emerging Technologies | Total | Water | Emerging Technologies | Total | |||||||
(In thousands) | ||||||||||||
Geographical market | ||||||||||||
Asia1 | $3,438 | $— | $3,438 | $1,979 | $— | $1,979 | ||||||
Middle East and Africa | 2,880 | 1 | 2,881 | 4,785 | 1 | 4,786 | ||||||
Europe | 1,075 | — | 1,075 | 1,386 | — | 1,386 | ||||||
Americas | 671 | — | 671 | 3,939 | — | 3,939 | ||||||
Total revenue | $8,064 | $1 | $8,065 | $12,089 | $1 | $12,090 | ||||||
Channel | ||||||||||||
Aftermarket | $4,027 | $1 | $4,028 | $4,643 | $1 | $4,644 | ||||||
Original equipment manufacturer | 4,001 | — | 4,001 | 3,346 | — | 3,346 | ||||||
Megaproject | 36 | — | 36 | 4,100 | — | 4,100 | ||||||
Total revenue | $8,064 | $1 | $8,065 | $12,089 | $1 | $12,090 | ||||||
March 31, 2025 | December 31, 2024 | |||
(In thousands) | ||||
Accounts receivable, net | $32,389 | $64,066 | ||
Contract assets, current (included in prepaid expenses and other assets) | $2,398 | $2,776 | ||
Contract liabilities: | ||||
Contract liabilities, current | $1,401 | $571 | ||
Total contract liabilities | $1,401 | $571 | ||
March 31, 2025 | December 31, 2024 | ||
(In thousands) | |||
Contract liabilities, beginning of year | $571 | $1,187 | |
Revenue recognized | (34) | (1,085) | |
Cash received, excluding amounts recognized as revenue during the period | 864 | 469 | |
Contract liabilities, end of period | $1,401 | $571 | |
Period | Remaining Performance Obligations | ||
(In thousands) | |||
2025 (remaining nine months) | $5,101 | ||
2026 | 3,418 | ||
Total | $8,519 |
Three Months Ended March 31, | ||||
2025 | 2024 | |||
(In thousands, except per share amounts) | ||||
Numerator | ||||
Net loss | $(9,880) | $(8,260) | ||
Denominator (weighted average shares) | ||||
Basic and dilutive common shares outstanding | 54,902 | 57,102 | ||
Net loss per share | ||||
Basic | $ (0.18) | $ (0.14) | ||
Diluted | $ (0.18) | $ (0.14) | ||
Three Months Ended March 31, | |||
2025 | 2024 | ||
(In thousands) | |||
Anti-dilutive equity award shares | 2,806 | 3,286 | |
March 31, 2025 | December 31, 2024 | ||
(In thousands) | |||
Cash and cash equivalents | $49,137 | $29,627 | |
Restricted cash, non-current (included in other assets, non-current) | 131 | 130 | |
Total cash, cash equivalents and restricted cash | $49,268 | $29,757 | |
March 31, 2025 | December 31, 2024 | ||
(In thousands) | |||
Accounts receivable, gross | $32,610 | $64,287 | |
Allowance for doubtful accounts | (221) | (221) | |
Accounts receivable, net | $32,389 | $64,066 | |
March 31, 2025 | December 31, 2024 | ||
(In thousands) | |||
Raw materials | $9,644 | $8,829 | |
Work in process | 8,054 | 6,417 | |
Finished goods | 15,582 | 10,463 | |
Inventories, gross | 33,280 | 25,709 | |
Valuation adjustments for excess and obsolete inventory | (870) | (803) | |
Inventories, net | $32,410 | $24,906 | |
March 31, 2025 | December 31, 2024 | ||
(In thousands) | |||
Accrued expenses and other liabilities, current | |||
Payroll, incentives and commissions payable | $4,932 | $10,179 | |
Warranty reserve | 1,002 | 1,090 | |
Restructuring accrual | 1,029 | 2,476 | |
Income taxes payable | 958 | 947 | |
Other accrued expenses and other liabilities | 3,351 | 3,036 | |
Total accrued expenses and other liabilities | 11,272 | 17,728 | |
Other liabilities, non-current | 96 | 57 | |
Total accrued expenses, and current and non-current other liabilities | $11,368 | $17,785 | |
Segment | Corporate | Total Expense | ||||||
Water | Emerging Technology | |||||||
(In thousands) | ||||||||
Amount recognized in 2024 | 1,147 | 832 | 497 | 2,476 | ||||
Amount recognized in 2025 | 210 | 123 | 206 | 539 | ||||
Total restructuring expenses recognized | $1,357 | $955 | $703 | $3,015 | ||||
Severance and Benefits | |
(In thousands) | |
Balance, as of December 31, 2024 | $2,476 |
Restructuring provision | 539 |
Cash paid | (1,986) |
Balance, as of March 31, 2025 | $1,029 |
March 31, 2025 | December 31, 2024 | ||||||||||||||||
Pricing Category | Amortized Cost | Gross Unrealized Gains | Gross Unrealized Losses | Fair Value | Amortized Cost | Gross Unrealized Gains | Gross Unrealized Losses | Fair Value | |||||||||
(In thousands) | |||||||||||||||||
Cash equivalents | |||||||||||||||||
Money market securities | Level 1 | $5,560 | $— | $— | $5,560 | $2,580 | $— | $— | $2,580 | ||||||||
U.S. treasury securities | Level 2 | 5,498 | — | — | 5,498 | — | — | — | — | ||||||||
Total cash equivalents | 11,058 | — | — | 11,058 | 2,580 | — | — | 2,580 | |||||||||
Short-term investments | |||||||||||||||||
U.S. treasury securities | Level 2 | 17,380 | 17 | — | 17,397 | 20,303 | 42 | — | 20,345 | ||||||||
Corporate notes and bonds | Level 2 | 16,970 | 41 | — | 17,011 | 27,995 | 52 | — | 28,047 | ||||||||
Total short-term investments | 34,350 | 58 | — | 34,408 | 48,298 | 94 | — | 48,392 | |||||||||
Long-term investments | |||||||||||||||||
U.S. treasury securities | Level 2 | 3,510 | 13 | — | 3,523 | 999 | 1 | — | 1,000 | ||||||||
Corporate notes and bonds | Level 2 | 14,598 | 66 | — | 14,664 | 18,983 | 65 | (13) | 19,035 | ||||||||
Municipal and agency notes and bonds | Level 2 | 4,999 | — | (1) | 4,998 | 1,799 | — | (2) | 1,797 | ||||||||
Total long-term investments | 23,107 | 79 | (1) | 23,185 | 21,781 | 66 | (15) | 21,832 | |||||||||
Total short and long-term investments | 57,457 | 137 | (1) | 57,593 | 70,079 | 160 | (15) | 70,224 | |||||||||
Total | $68,515 | $137 | $(1) | $68,651 | $72,659 | $160 | $(15) | $72,804 | |||||||||
March 31, 2025 | December 31, 2024 | ||||||
Fair Value | Gross Unrealized Losses | Fair Value | Gross Unrealized Losses | ||||
(In thousands) | |||||||
Corporate notes and bonds | — | — | 7,569 | (13) | |||
Municipal and agency notes and bonds | 3,997 | (1) | 1,797 | (2) | |||
Total available-for-sale investments with unrealized loss positions | $3,997 | $(1) | $9,366 | $(15) | |||
March 31, 2025 | December 31, 2024 | ||
(In thousands) | |||
Outstanding letters of credit | $15,675 | $15,708 | |
Three Months Ended March 31, | |||
2025 | 2024 | ||
(In thousands, except percentages) | |||
Benefit from income taxes | $(1,603) | $(1,285) | |
Discrete items | 52 | 76 | |
Benefit from income taxes, excluding discrete items | $(1,551) | $(1,209) | |
Effective tax rate | 14.0% | 13.5% | |
Effective tax rate, excluding discrete items | 13.5% | 12.7% | |
Three Months Ended March 31, 2025 | Three Months Ended March 31, 2024 | ||||||||||||||
Water | Emerging Technologies | Corporate | Total | Water | Emerging Technologies | Corporate | Total | ||||||||
(In thousands) | |||||||||||||||
Revenue | $8,064 | $1 | $— | $8,065 | $12,089 | $1 | $— | $12,090 | |||||||
Cost of revenue | 3,561 | 46 | — | 3,607 | 4,954 | 1 | — | 4,955 | |||||||
Gross profit (loss) | 4,503 | (45) | — | 4,458 | 7,135 | — | — | 7,135 | |||||||
Operating expenses | |||||||||||||||
General and administrative | 1,573 | 755 | 6,246 | 8,574 | 1,922 | 1,018 | 4,626 | 7,566 | |||||||
Sales and marketing | 3,145 | 1,270 | 491 | 4,906 | 3,745 | 1,807 | 600 | 6,152 | |||||||
Research and development | 1,178 | 1,823 | — | 3,001 | 1,100 | 3,251 | — | 4,351 | |||||||
Restructuring charges | 210 | 123 | 206 | 539 | — | — | — | — | |||||||
Total operating expenses | 6,106 | 3,971 | 6,943 | 17,020 | 6,767 | 6,076 | 5,226 | 18,069 | |||||||
Operating income (loss) | $(1,603) | $(4,016) | $(6,943) | $(12,562) | $368 | $(6,076) | $(5,226) | $(10,934) | |||||||
Three Months Ended March 31, | ||||||
Segment | 2025 | 2024 | ||||
Customer A | Water | 12% | ** | |||
Customer B | Water | ** | 18% | |||
Customer C | Water | ** | 13% | |||
Number of Shares Purchased | Average Price Paid per Share(1) | Plan Activity | |||||
(In millions) | |||||||
February 2025 Authorization | $30.0 | ||||||
Repurchases under February 2025 Authorization | 279,295 | $16.07 | (4.5) | ||||
Remaining amount under February 2025 Authorization | $25.5 |
Three Months Ended March 31, | |||||||||||
2025 | 2024 | ||||||||||
Revenue | % of Revenue | Revenue | % of Revenue | Change | |||||||
(In thousands, except percentages) | |||||||||||
Aftermarket | $4,028 | 50% | $4,644 | 38% | $(616) | (13%) | |||||
Original equipment manufacturer | 4,001 | 50% | 3,346 | 28% | 655 | 20% | |||||
Megaproject | 36 | —% | 4,100 | 34% | (4,064) | (99%) | |||||
Total revenue | $8,065 | 100% | $12,090 | 100% | $(4,025) | (33%) | |||||
Three Months Ended March 31, | |||||||||||
2025 | 2024 | ||||||||||
Water | Emerging Technologies | Total | Water | Emerging Technologies | Total | ||||||
(In thousands) | |||||||||||
Asia1 | $3,438 | $— | $3,438 | $1,979 | $— | $1,979 | |||||
Middle East and Africa | 2,880 | 1 | 2,881 | 4,785 | 1 | 4,786 | |||||
Europe | 1,075 | — | 1,075 | 1,386 | — | 1,386 | |||||
Americas | 671 | — | 671 | 3,939 | — | 3,939 | |||||
Total revenue | $8,064 | $1 | $8,065 | $12,089 | $1 | $12,090 | |||||
Three Months Ended March 31, | |||||
2025 | 2024 | Change | |||
(In thousands, except percentage and basis point) | |||||
Gross profit | $4,458 | $7,135 | $(2,677) | ||
Gross margin | 55.3% | 59.0% | (370) bps | ||
Three Months Ended March 31, | ||||||||||||||||
2025 | 2024 | |||||||||||||||
Water | Emerging Technologies | Corporate | Total | Water | Emerging Technologies | Corporate | Total | |||||||||
(In thousands) | ||||||||||||||||
General and administrative | $1,573 | $755 | $6,246 | $8,574 | $1,922 | $1,018 | $4,626 | $7,566 | ||||||||
Sales and marketing | 3,145 | 1,270 | 491 | 4,906 | 3,745 | 1,807 | 600 | 6,152 | ||||||||
Research and development | 1,178 | 1,823 | — | 3,001 | 1,100 | 3,251 | — | 4,351 | ||||||||
Restructuring charges | 210 | 123 | 206 | 539 | — | — | — | — | ||||||||
Total operating expenses | $6,106 | $3,971 | $6,943 | $17,020 | $6,767 | $6,076 | $5,226 | $18,069 | ||||||||
Three Months Ended March 31, | |||
2025 | 2024 | ||
(In thousands) | |||
Interest income | $1,073 | $1,442 | |
Other non-operating income (expense), net | 6 | (53) | |
Total other income, net | $1,079 | $1,389 | |
Three Months Ended March 31, | |||
2025 | 2024 | ||
(In thousands, except percentages) | |||
Benefit from income taxes | $(1,603) | $(1,285) | |
Discrete items | 52 | 76 | |
Benefit from income taxes, excluding discrete items | $(1,551) | $(1,209) | |
Effective tax rate | 14.0% | 13.5% | |
Effective tax rate, excluding discrete items | 13.5% | 12.7% | |
Three Months Ended March 31, | |||||
2025 | 2024 | Change | |||
(In thousands) | |||||
Net cash provided by operating activities | $10,678 | $6,497 | $4,181 | ||
Net cash provided by (used in) investing activities | 12,674 | (4,986) | 17,660 | ||
Net cash (used in) provided by financing activities | (3,874) | 1,190 | (5,064) | ||
Effect of exchange rate differences on cash and cash equivalents | 33 | (19) | 52 | ||
Net change in cash, cash equivalents and restricted cash | $19,511 | $2,682 | $16,829 | ||
Exhibit Number | Exhibit Description | |
31.1* | ||
31.2* | ||
32.1** | ||
101 | Inline XBRL Document Set for the consolidated financial statements and accompanying notes in Part I, “Financial Information” of this Quarterly Report on Form 10-Q. | |
104 | Inline XBRL for the cover page of this Quarterly Report on Form 10-Q, included in the Exhibit 101 Inline XBRL Document Set. | |
ENERGY RECOVERY, INC. | |||||
Date: | May 7, 2025 | By: | /s/ DAVID W. MOON | ||
David W. Moon | |||||
President and Chief Executive Officer | |||||
(Principal Executive Officer) | |||||
Date: | May 7, 2025 | By: | /s/ MICHAEL S. MANCINI | ||
Michael S. Mancini | |||||
Chief Financial Officer | |||||
(Principal Financial Officer) | |||||